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Although neuroblastoma is a common solid organ malignancy in children, primary
pancreatic neuroblastoma is a rare entity in children, with very few cases reported in the
literature. The case discusses the presentation of a 21-month-old female presenting to the
neurology clinic with ataxia and erratic eye movements. Our case illustrates the computed
tomography, ultrasound, and scintigraphic findings of primary pancreatic neuroblastoma
presenting as opsoclonusemyoclonus syndrome. Computed tomography and ultrasound
demonstrated a vascular, enhancing mass in the pancreatic body clearly separate from the
adrenal gland. Metaiodobenzylguanidine scan demonstrates focal intense uptake in the
pancreatic body. The patient's diagnosis was confirmed with biopsy, and her malignancy
responded well to conventional chemotherapy. The case is important in that it demon-
strates the unusual imaging appearance of a primary pancreatic neuroblastoma.
Copyright © 2016, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Neuroblastoma is the thirdmost commonpediatricmalignancy
and the most common extracranial solid organ malignancy in
children[1].Approximately30-35%ofneuroblastomasareextra-
adrenal in origin and located in the retroperitoneum. However,
these tumors can arise from neural crest cells anywhere in the
body.Althougha common tumor ingeneral inchildren,primary
pancreatic neuroblastoma is quite rare in children and very few
cases have been reported in the literature since 1969, several of
which represent pancreatic involvement following relapse or
disease progression [2e8]. We discuss a rare case of neuroblas-
toma arising primarily from the pancreas and illustrate thedu (S. Galgano).
blished by Elsevier Inc. u
ND license (http://creativfindings on computed tomography (CT), ultrasound, and Meta-
iodobenzylguanidine (MIBG) scan imaging.Case report
A full-term 21-month-old female presented to the pediatric
neurology clinic with chronic ataxia. The symptoms began 9
months before presentation in the neurology clinic. Nine
months before presentation, the patient was admitted to the
neurology service and was diagnosed with acute cerebellar
ataxia. Per the family, the patient never recovered, and the
patient did not relearn to walk until 15 months. The patientnder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1 e (A-D) Sagittal T1 (A), axial T2 fluid-attenuation inversion recovery (FLAIR) (B), axial T2 turbo spin echo (TSE) (C), and
axial postcontrast T1 (D) images of the brain demonstrate a normal appearing cerebellum.
Fig. 2 e (A and B) Axial computed tomography image of the abdomen demonstrating a heterogeneously enhancing mass in
the pancreatic body and tail (A) with encasement of the celiac axis (B).
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Fig. 3 e (A and B) Ultrasound images demonstrate a heterogeneous mass in the pancreatic body and/or tail (A) with
increased vascularity on color Doppler that encases nearby vessels (B).
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 3 6e4 038walkedwith an unsteady gait and had intermittent jerkswhile
moving. In addition, the patient also had spells of erratic
eye movements starting 3 months before presentation in the
neurology clinic, occurring several times per day. There were
no clinical manifestations or family history of Beck-
witheWiedemann syndrome or neurofibromatosis type 1.
Physical examination demonstrated absent deep tendon
reflexes, a downgoing Babinski sign, ataxic wide-based gait,
mild hypotonia, and dysmetria when grasping for objects.
Two prior brainmagnetic resonance imaging studies with and
without the use of intravenous contrast (Figs. 1A-D) and
electroencephalogram were within normal limits. Given theFig. 4 e A 24-hour delayed I-123 MIBG images demonstrated foc
and/or tail without metastatic disease.broad differential for ataxia with areflexia and myoclonus, a
thorough laboratory investigation was performed. All of the
patient's initial laboratory results were within normal limits
with the exception of an elevated urine vanillylmandelic acid,
which measured 26.7 mg/g creatinine (normal value, 0-18.8
mg/g creatinine).
Thus, a CT of the chest, the abdomen, and the pelvis were
performed for the suspicion of neuroblastoma and opsoclo-
nusemyoclonus syndrome. The CT was performed using the
routine protocol at our institution using 23 mL of intrave-
nously injected Optiray-320 and imaged 60 seconds following
injection in portal venous phase. No oral contrast wasal intense tracer uptake in the region of the pancreatic body
Fig. 5 e (A and B) Histopathology demonstrating sheets of neuroblastoma cells infiltrating pancreatic parenchyma
(hematoxylin and eosin stain, £ 33 [A], and £ 132 [B]).
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 3 6e4 0 39administered. The CT revealed a 3.6  3.2  2.8 cm enhancing
mass in the body and the tail of the pancreas encasing the
celiac axis (Figs. 2A and B). Please note, the high-attenuation
appearance of the kidneys in Figures 2A and B is secondary
to window width and/or level. A confirmatory abdominal ul-
trasound was performed, which demonstrated a lobular,
heterogeneous, well-circumscribed mass in the region of the
pancreatic tail with increased vascularity on color Doppler
images (Figs. 3A and B). Follow-up laboratory studies alsowere
notable for an elevated serum epinephrine at 129 pg/mL
(normal value, 0-80 pg/mL). Given the presumed diagnosis of a
neuroblastoma, a nuclear medicine MIBG scan was per-
formed. The patient was intravenously injected with 5.2 mCiFig. 6 e (A-C) Postchemotherapy contrast-enhanced axial (A an
abdomen and the pelvis demonstrate no evidence of residual dof I-123 MIBG and imaged at 24 hours postinjection. The im-
ages demonstrated intense focal uptake in the region of the
pancreatic tail without evidence of distant metastasis (Fig. 4).
Although the patient was deemed unresectable based on the
results of the imaging, the patient ultimately underwent sur-
gical biopsy for pathologic conformation. The final pathology
indicated a poorly differentiated neuroblastoma infiltrating
adjacent pancreatic parenchyma (Figs. 5A and B). The tumor
was classified as unfavorable histology by the Shimada index
and did not demonstrate amplification of the n-myc oncogene.
The patient underwent chemotherapy and follow-up CT scans
demonstrated decrease in tumor size, with no CT evidence of
residual or recurrent disease at 10 months (Figs. 6A-C).d B) and coronal (C) computed tomography images of the
isease.
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Neuroblastoma is the most common solid organ extracranial
childhood malignancy and arises from primitive neural crest
cells [1]. The typical location of these tumors is the adrenal
glands, but neuroblastoma can arise from neural crest cells
anywhere in the body, the most commonly the extra-adrenal
retroperitoneum and posterior mediastinum. The presence of
a neuroblastoma can be suggested with increased urine cat-
echolamines, but ultimately advanced imaging such as CT or
magnetic resonance imaging of the chest, the abdomen, and
the pelvis is required to search for the primary tumor and for
staging if a mass is detected. The diagnosis can also be
confirmed by MIBG imaging, which may demonstrate occult
metastases. There are 2 well-documented paraneoplastic
syndromes associated with neuroblastoma: opsoclo-
nusemyoclonus syndrome and watery diarrhea with hypo-
kalemia syndrome [1]. The exact pathophysiology of
opsoclonusemyoclonus syndrome is not known, but specu-
lated to be an autoimmune phenomenon. Although only 2% of
neuroblastomas present with opsoclonusemyoclonus syn-
drome, the clinical diagnosis should prompt a search for
neuroblastoma, with approximately 50% of patients present-
ing with opsoclonusemyoclonus syndrome having neuro-
blastoma [1]. Watery diarrhea with hypokalemia syndrome is
caused by excess secretion of vasoactive intestinal peptides
and catecholamines [1].
Primary pancreatic neuroblastoma remains a very rare
manifestation of a common disease. However, given the fre-
quency it is encountered in pediatric radiology, it remains
important for the radiologist to consider neuroblastoma in
any organ with neural crest progenitor cells. As demonstrated
in this case, multimodality imaging with radiography, CT,
ultrasound, and nuclear medicine is the mainstay ofdiagnosis, staging, and tracking response to therapy. Imaging
features of primary pancreatic neuroblastoma do not differ
significantly from neuroblastomas arising in typical locations,
so any lesion suspicious for neuroblastoma should be imaged
with an appropriate modality and ultimately biopsied if there
is any clinical doubt. Elevated urine catecholamines can sug-
gest the presence of neuroblastoma, but a work-up should be
undertaken in any patient presenting with either of the afore-
mentioned paraneoplastic syndromes.
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